Learn how to build decision-grade disease registries that turn real-world data into reliable evidence for regulatory, clinical, and market-access decisions.
- Inside A Sponsor-Site Relationship That Actually Worked
- Real-World Data Won't Replace Trials. Here's Its Real Job
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
- What Ecological Momentary Assessment Taught Us About Real-World Hearing Outcomes
- AI Governance Is Becoming A Competitive Edge In Trials
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?
- From 73% Noncompliant To 2.4%: Building A Compliance Office
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How Vanguard Clinical Harnesses CDMS/EDC For Faster Results
Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.
-
AI, Virtual Participants, and the Evolving FDA Regulatory Landscape
Understanding emerging requirements around transparency, risk, and governance is essential for responsibly advancing AI-driven innovation in regulated environments.
-
Clinical Trial Logistics: Meeting Unique Participant Needs
Uncover why delivering a comprehensive service entails establishing a robust global network equipped with the expertise, resources, and adaptability to address diverse participant needs worldwide.
-
Accelerating Your New Therapies Path To Market With Automation
Automation has become an essential tool for addressing the inefficiencies in traditional clinical trial methodologies, enabling trial teams to instead concentrate on critical tasks such as patient care.
-
Partnership Driving Superior Enrollment And Speed In Phase III Trial
Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.
-
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
What Happened At ASCO 2024
Discover our associates' insights on the key developments from ASCO 2024 that are set to shape the future of cancer care and patient outcomes.
-
Killing Excel: The Quiet Crisis In Clinical Trials
Stop relying on spreadsheets for critical clinical trial decisions. Learn how standardizing vendor selection eliminates inefficiencies and protects budgets.
-
What Patients Are Asking For In Clinical Trials
Global insights show how travel demands, uneven compensation, and overlooked caregiver burden undermine trial participation — making flexible, patient-centered approaches essential.
-
Why eSource: The Advantages of Abandoning Paper Records
Eliminate transcription errors and fully leverage supporting eClinical technology to provide a reliable consistent exchange of information.
RECENT NEWSLETTERS
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps